missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human EVER2 Synthetic Peptide
Description
This peptide corresponds to 14 amino acids near the center of human EVER2. PEP-0646 can be used as a blocking peptide with polyclonal antibody PA5-20526.
Epidermodysplasia verruciformis (EV) is an autosomal recessive genodermatosis associated with a high risk of skin cancers resulting from a high susceptibility to infection by specific human papillomaviruses. Mutations in two homologous genes EVER1 and EVER2 cause the majority of EV cases. These two proteins form a complex and interact with the zinc transporter ZnT-1 in the endoplasmic reticulum. Cells lacking EVER2 accumulated higher levels of zinc in the nucleolus and nucleus compare to those cells with and intact EVER2 gene, indicating that one role of EVER2 is to regulate the intracellular distribution of zinc.
Specifications
Specifications
| Species | Human |
| Purification Method | purified |
| Accession Number | Q8IU68 |
| Common Name | EVER2 |
| Concentration | 200 μg/mL |
| Format | Liquid |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Gene Alias | epidermodysplasia verruciformis 2; epidermodysplasia verruciformis protein 2; Epidermodysplasia verruciformis protein 2 homolog; EV2; Ever2; EVIN2; mFLJ00400; Tmc8; transmembrane channel like 8; transmembrane channel-like 8; transmembrane channel-like gene family 8; transmembrane channel-like protein 8 |
| Gene Symbol | TMC8 |
| Lyophilized | No |
| Show More |